1463.05 47.45 (3.35%)

2.4M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

US FDA Approval
Cipla gets US FDA nod for ANDA of Paclitaxel injectable suspension with a market size of $88 bn See details

Cipla Ltd. - CIPLA - stock price prediction, stock forecast, target price, analyst ratings from 37 analysts

Cipla Ltd. has a share price target of Rs 1642, revenue growth forecast of 6.8%, and profit growth estimate of 21.0% for FY25, based on top 37 analyst calls.